| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $7,637,930 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30CA278348 | Metabolic Obesity Phenotypes and Obesity-related Cancer Survival | 000 | 2 | NIH | 11/14/2024 | $53,974 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | AY2AX000070 | Rural Huntsman at Home: Maneuvering a Paradigm Shift in Cancer Care | 000 | 1 | NIH | 11/15/2024 | $3,955,826 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL167866 | Pathobiological mechanisms of cardiac disease in PGM1-CDG | 000 | 2 | NIH | 11/14/2024 | $586,682 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AR081006 | Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial | 000 | 3 | NIH | 11/8/2024 | $152,460 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI175494 | Mechanisms of T cell persistence during chronic autoimmunity | 000 | 2 | NIH | 10/31/2024 | $648,623 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01ES024681 | BIOLOGICAL FATE AND BIOCOMPATIBILITY OF SILICA-BASED NANOCONSTRUCTS | 000 | 14 | NIH | 11/15/2024 | $461,025 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI173406 | Early life regulation of microbiota specific thymic T cell development | 000 | 3 | NIH | 11/1/2024 | $792,545 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21CA286375 | Quantitative evaluation of focused ultrasound thermal therapy on immunogenic cell death in breast cancer | 000 | 2 | NIH | 11/4/2024 | $194,387 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA121118 | A High-Throughput Model for Human Melanoma | 000 | 15 | NIH | 11/7/2024 | $260,775 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01ES032553 | Role of Surfactant Protein-C Mutation and Ozone Exposure in the Exacerbation of Pulmonary Fibrosis | 000 | 5 | NIH | 11/6/2024 | $383,172 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI168714 | Cellular mechanisms linking the intestine to inflammation involving non-intestinal organs | 000 | 2 | NIH | 11/1/2024 | $186,725 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T9952113 | Value-Based Medical Student Education Training Program | 01 | 2 | HRSA | 11/5/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | NU01DD000022 | Utah MATernaL and Infant NetworK (Utah MAT-LINK):Ongoing Pregnant People-Infant Linked Longitudinal Surveillance Effort for Opioid Use Disorder, Neonatal Abstinence Syndrome, and Polysubstance Use | 01 | 2 | CDC | 11/18/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | NU01DD000022 | Utah MATernaL and Infant NetworK (Utah MAT-LINK):Ongoing Pregnant People-Infant Linked Longitudinal Surveillance Effort for Opioid Use Disorder, Neonatal Abstinence Syndrome, and Polysubstance Use | 01 | 2 | CDC | 11/18/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U1U42531 | Regional Telehealth Resource Centers | 08 | 3 | HRSA | 11/15/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U54CK000602 | Intermountain Program on Antibiotic Resistance and microbial Threats (IMPART) | 01 | 4 | CDC | 11/18/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T9432908 | Advanced Nursing Education Workforce | 01 | 6 | HRSA | 11/5/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM124780 | Investigating the impact of genetic variation on the ER stress response, protein folding, and disease | 000 | 8 | NIH | 11/8/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | H4B15602 | Poison Control Stabilization and Enhancement Program | 01 | 16 | HRSA | 10/16/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM128804 | Large-scale regulation of meiotic chromosome dynamics | 000 | 7 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23MH135225 | Examining Mechanisms of Change in Adolescent Self-Inflicted Injury | 000 | 1 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM119694 | Investigating the Mitochondrial-Derived Compartment Pathway | 000 | 9 | NIH | 11/8/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R61HL171790 | Trans Nasal Transesophageal Echocardiography | 000 | 1 | NIH | 11/16/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31CA261116 | Investigating KRAS Signaling and Autophagy Co-inhibition in KRAS-mutant Lung Cancer | 000 | 3 | NIH | 11/14/2024 | -$14,112 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM126956 | Discovery and mechanisms of biosynthetic enzymes | 000 | 7 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | PL1HD105462 | Collaborative Pediatric Critical Care Research Network | 000 | 4 | NIH | 10/30/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM134936 | Evolutionary innovations from host-microbe interactions | 000 | 5 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM140900 | Regulation of cell growth and proliferation | 000 | 4 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM141262 | Elucidating roles and mechanisms of double-stranded RNA-mediated pathways | 000 | 4 | NIH | 11/15/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM148283 | Symbiosis and Chemical Diversity Generation | 000 | 2 | NIH | 11/11/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AR082574 | Metformin as a novel, mechanistic treatment of fibromyalgia; a proof of concept RCT | 000 | 2 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM153284 | New Tools for Visualizing Dynamic Molecular Complexes | 000 | 1 | NIH | 11/4/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM133772 | Visualizing the Mechanisms of Protein Quality Control | 000 | 6 | NIH | 11/4/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DC019127 | Regulation of inner ear development by FGF signals and effectors | 000 | 4 | NIH | 11/7/2024 | -$44,209 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM133672 | G protein-coupled receptor signaling in development and disease: Hedgehog and beyond | 000 | 6 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM136271 | Data Science Guided Organic Reaction Development | 000 | 5 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS137233 | PASK-regulated genes and proteins as therapeutic targets for ALS and FTD | 000 | 1 | NIH | 10/24/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NR021501 | Enhanced Digital Access to Bridge Social Needs and Reduce Health Disparities: The e-SINCERE Study | 000 | 1 | NIH | 10/23/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | NU01DD000046 | Surveillance of Spina Bifida across the Life - Utah Center COMPONENT A | 01 | 1 | CDC | 10/24/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T2653692 | Opioid-Impacted Family Support Program | 01 | 1 | HRSA | 11/14/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T8R53148 | Primary Care Training and Enhancement: Physician Assistant Rural Training in Mental and Behav. Hlth | 02 | 1 | HRSA | 10/10/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35DE034352 | Advancing oral health equity through integrating patient, provider, and population-based approaches | 000 | 1 | NIH | 10/16/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM136389 | Chromosome breakage, pairing and replication: impacts on cell fate and function | 000 | 5 | NIH | 11/7/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM136430 | Development and Application of Nicotinic Acetylcholine Receptor Targeted Peptides for Biomedical Research | 000 | 5 | NIH | 11/13/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM144241 | Novel functions for Sm-class RNAs in the regulation of gene expression | 000 | 3 | NIH | 11/7/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DC017466 | Mechanisms of temporal selectivity in the anuran auditory midbrain | 000 | 5 | NIH | 10/15/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21CA264627 | The role of tumor endothelium-specific prion-gene PRND in epithelial ovarian cancer | 003 | 3 | NIH | 10/10/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21CA264627 | The role of tumor endothelium-specific prion-gene PRND in epithelial ovarian cancer | 002 | 3 | NIH | 10/9/2024 | $46,348 |
| | 2025 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | NU01DD000022 | Utah MATernaL and Infant NetworK (Utah MAT-LINK):Ongoing Pregnant People-Infant Linked Longitudinal Surveillance Effort for Opioid Use Disorder, Neonatal Abstinence Syndrome, and Polysubstance Use | 01 | 2 | CDC | 11/18/2024 | $0 |
|
